The European drug regulator on Friday recommended approving Moderna's coronavirus vaccine, called Spikevax, for use in children aged 12-17 years, making it the second vaccine to be authorized for this age group in the region. The European Medicines Agency (EMA) said a study involving over 3,700 children aged 12-17 years showed Spikevax triggered immune responses similar to those in young adults. Here's more.
source https://www.newsbytesapp.com/news/world/ema-approves-moderna-covid-19-vaccine-for-children-aged-12-17/story
source https://www.newsbytesapp.com/news/world/ema-approves-moderna-covid-19-vaccine-for-children-aged-12-17/story
إرسال تعليق